Skin Structure, Function, and Permeation

Transdermal and Topical Drug Delivery: Principles and Practice

Volumn , Issue , 2012, Pages 1-22

  Benson, Heather A E ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

Skin permeation, and pathways with lipid ordering; Skin, physiological affecting skin barrier and permeability; Stratum corneum, an efficient physical barrier, enzymes and NMF

Indexed keywords

EID: 84885970506     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118140505.ch1     Document Type: Chapter

References (98)

1. Zeeuwen PL. Epidermal differentiation: The role of proteases and their inhibitors. Eur J Cell Biol 2004; 83: 761-773.
2. Hachem J-P, Man M-Q, Crumrine D, et al. Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. J Invest Dermatol 2005; 125: 510-520.
3. Meyer T, Stockfl eth E, Chrstophers E. Immune response profiles in human skin. Br J Dermatol 2007; 157: 1-7.
4. Dowling J, Yu QC, Fuchs E. Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. J Cell Biol 1996; 134: 559-572.
5. Burgeson RE, Christiano AM. The dermal-epidermal junction. Curr Opin Cell Biol 1997; 9: 651-658.
6. Hearing VJ. Biochemical control of melanogenesis and melanosomal organization. J Investig Dermatol Symp Proc 1999; 4: 24-28.
7. Tachibana T, Nawa T. Recent progress in studies on Merkel cell biology. Anat Sci Int 2002; 77: 26-33.
8. Tachibana T. The Merkel cell: Recent findings and unresolved problems. Arch Histol Cytol 1995; 58: 379-396.
9. Landmann L. The epidermal permeability barrier. Anat Embryol (Berl) 1988; 178: 1-13.
10. Lundstrom A, Egelrud T. Stratum corneum chymotryptic enzyme: A proteinase which may be generally present in the stratum corneum and with a possible involvement in desquamation. Acta Derm Venereol 1991; 71: 471-474.
11. Egelrud T. Purifi cation and preliminary characterization of stratum corneum chymotryptic enzyme: A proteinase that may be involved in desquamation. J Invest Dermatol 1993; 101: 200-204.
12. Ekholm E, Egelrud T. Stratum corneum chymotryptic enzyme in psoriasis. Arch Dermatol Res 1999; 291: 195-200.
13. Vasilopoulos Y, Cork MJ, Murphy R, et al. Genetic association between an AACC insertion in the 3'UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. J Invest Dermatol 2004; 123: 62-66.
14. Elias PM. Epidermal lipids, membranes, and keratinization. Int J Dermatol 1981; 20: 1-19.
15. Michaels AS, Chandrasekaran SK, Shaw JE. Drug permeation through human skin: Theory and in vitro experimental measurement. AIChE J 1975; 21: 985-996.
16. Nemes Z, Steinert PM. Bricks and mortar of the epidermal barrier. Exp Mol Med 1999; 31: 5-19.
17. Lazo ND, Meine JG, Downing DT. Lipids are covalently attached to rigid corneocyte protein envelopes existing predominantly as beta-sheets: A solid-state nuclear magnetic resonance study. J Invest Dermatol 1995; 105: 296-300.
18. Behne M, Uchida Y, Seki T, et al. Omega-hydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function. J Invest Dermatol 2000; 114: 185-192.
19. Wartewig S, Neubert RH. Properties of ceramides and their impact on the stratum corneum structure: A review. Part 1: Ceramides. Skin Pharmacol Physiol 2007; 20: 220-229.
20. Lampe MA, Burlingame AL, Whitney J, et al. Human stratum corneum lipids: Characterization and regional variations. J Lipid Res 1983; 24: 120-130.
21. Masukawa Y, Narita H, Sato H, et al. Comprehensive quantifi cation of ceramide species in human stratum corneum. J Lipid Res 2009; 50: 1708-1719.
22. Masukawa Y, Narita H, Shimizu E, et al. Characterization of overall ceramide species in human stratum corneum. J Lipid Res 2008; 49: 1466-1476.
23. Masukawa Y, Tsujimura H, Narita H. Liquid chromatography-mass spectrometry for comprehensive profi ling of ceramide molecules in human hair. J Lipid Res 2006; 47: 1559-1571.
24. Norlen L, Nicander I, Lundsjo A, et al. A new HPLC-based method for the quantitative analysis of inner stratum corneum lipids with special reference to the free fatty acid fraction. Arch Dermatol Res 1998; 290: 508-516.
25. Bouwstra J, Pilgram G, Gooris G, et al. New aspects of the skin barrier organization. Skin Pharmacol Appl Skin Physiol 2001; 14 (Suppl 1): 52-62.
26. Bouwstra J, Ponec M. The skin in healthy and diseased state. Biochim Biophys Acta 2006; 1758: 2080-2095.
27. Pilgram GS, Engelsma-Van Pelt AM, Bouwstra JA, et al. Electron diffraction provides new information on human stratum corneum lipid organization studied in relation to depth and temperature . J Invest Dermatol 1999; 113: 403-409.
28. Pilgram GS, van der Meulen J, Gooris GS, et al. The influence of two azones and sebaceous lipids on the lateral organization of lipids isolated from human stratum corneum. Biochim Biophys Acta 2001; 1511: 244-254.
29. Suhonen TM, Bouwsta JA, Urtti A. Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. J Control Rel 1999; 59: 149-161.
30. Rawlings AV, Matts PJ. Stratum corneum moisturization at the molecular level: An update in relation to the dry skin cycle. J Invest Dermatol 2005; 124: 1099-1110.
31. Walters KA, Roberts MS. The structure and function of skin. In: Walters KA, ed. Dermatological and Transdermal Formulations. Marcel Dekker, New York, 2002.
32. Hale AR, Burch GE. The arteriovenous anastomoses and blood vessels of the human fi nger. Morphological and functional aspects. Medicine (Baltimore) 1960; 39: 191-240.
33. Cross SE, Roberts MS. Subcutaneous absorption kinetics and local tissue distribution of interferon and other solutes. J Pharm Pharmacol 1993; 45: 606-609.
34. Lober CW, Fenske NA. Photoaging and the skin: Differentiation and clinical response. Geriatrics 1990; 45: 36-40.
35. Fenske NA, Lober CW. Structural and functional changes of normal aging skin. J Am Acad Dermatol 1986; 15: 571-585.
36. Batisse D, Bazin R, Baldeweck T, et al. Infl uence of age on the wrinkling capacities of skin. Skin Res Technol 2002; 8: 148-154.
37. Rogers J, Harding C, Mayo A, et al. Stratum corneum lipids: The effect of ageing and the seasons. Arch Dermatol Res 1996; 288: 765-770.
38. Takahashi M, Watanabe H, Kumagai H, et al. Physiological and morphological changes in facial skin with aging (II). J Soc Cosmet Chem Japan 1989; 23: 22-30.
39. Shriner DL, Maibach HI. Regional variation of nonimmunologic contact urticaria. Functional map of the human face. Skin Pharmacol 1996; 9: 312-321.
40. Wilhelm KP, Cua AB, Maibach HI. Skin aging. Effect on transepidermal water loss, stratum corneum hydration, skin surface pH, and casual sebum content. Arch Dermatol 1991; 127: 1806-1809.
41. Marrakchi S, Maibach HI. Sodium lauryl sulfate-induced irritation in the human face: Regional and age-related differences. Skin Pharmacol Physiol 2006; 19: 177-180.
42. Roskos KV, Bircher AJ, Maibach HI, et al. Pharmacodynamic measurements of methyl nicotinate percutaneous absorption: The effect of aging on microcirculation. Br J Dermatol 1990; 122: 165-171.
43. Roskos KV, Guy RH. Assessment of skin barrier function using transepidermal water loss: Effect of age. Pharm Res 1989; 6: 949-953.
44. Kalia YN, Nonato LB, Lund CH, et al. Development of skin barrier function in premature infants. J Invest Dermatol 1998; 111: 320-326.
45. Giusti F, Martella A, Bertoni L, et al. Skin barrier, hydration, and pH of the skin of infants under 2 years of age. Pediatr Dermatol 2001; 18: 93-96.
46. Williams ML, Feingold KR. Barrier function of neonatal skin. J Pediatr 1998; 133: 467-468.
47. Yosipovitch G, Maayan-Metzger A, Merlob P, et al. Skin barrier properties in different body areas in neonates. Pediatrics 2000; 106: 105-108.
48. Feldman R, Maibach HI. Absorption of some organic compounds through the skin in man. J Invest Dermatol 1970; 54: 399-404.
49. Rougier A, Dupuis D, Lotte C, et al. Regional variation in percutaneous absorption in man: Measurement by the stripping method. Arch Dermatol Res 1986; 278: 465-469.
50. Marrakchi S, Maibach HI. Biophysical parameters of skin: Map of human face, regional, and age-related differences. Contact Dermatitis 2007; 57: 28-34.
51. Berardesca E, Maibach HI. Racial differences in sodium lauryl sulphate induced cutaneous irritation: Black and white. Contact Dermatitis 1988; 18: 65-70.
52. Kompaore F, Marty JP, Dupont C. In vivo evaluation of the stratum corneum barrier function in blacks, Caucasians and Asians with two noninvasive methods. Skin Pharmacol 1993; 6: 200-207.
53. Warrier AG, Kligman AM, Harper RA, et al. A comparison of black and white skin using noninvasive methods. J Soc Cosmet Chem 1996; 47: 229-240.
54. Muizzuddin N, Hellemans L, Van Overloop L, et al. Structural and functional differences in barrier properties of African American, Caucasian and East Asian skin. J Dermatol Sci 2010; 59: 123-128.
55. Hillebrand GG, Wickett RR. Epidemiology of skin barrier function: Host and environmental factors. In: Walters KA, Roberts MS, eds. Dermatologic, Cosmeceutic and Cosmetic Development. Informa Healthcare, New York, 2008; 129-156.
56. Cua AB, Wilhelm KP, Maibach HI. Frictional properties of human skin: Relation to age, sex and anatomical region, stratum corneum hydration and transepidermal water loss. Br J Dermatol 1990; 123: 473-479.
57. Fluhr JW, Pelosi A, Lazzerini S, et al. Differences in corneocyte surface area in pre-and post - menopausal women. Assessment with the noninvasive videomicroscopic imaging of corneocytes method (VIC) under basal conditions. Skin Pharmacol Appl Skin Physiol 2001; 14 (Suppl 1): 10-16.
58. Harvell J, Hussona-Saeed I, Maibach HI. Changes in transepidermal water loss and cutaneous blood flow during the menstrual cycle. Contact Dermatitis 1992; 27: 294-301.
59. Muizzuddin N, Marenus KD, Schnittger SF, et al. Effect of systemic hormonal cyclicity on skin. J Cosmet Sci 2005; 56: 311-321.
60. Aalto-Korte K, Turpeinen M. Transepidermal water loss and absorption of hydrocortisone in widespread dermatitis. Br J Dermatol 1993; 128: 633-635.
61. Aalto-Korte K, Turpeinen M. Quantifying systemic absorption of topical hydrocortisone in erythroderma. Br J Dermatol 1995; 133: 403-408.
62. Aalto-Korte K, Turpeinen M. Pharmacokinetics of topical hydrocortisone at plasma level after applications once or twice daily in patients with widespread dermatitis. Br J Dermatol 1995; 133: 259-263.
63. Aalto-Korte K, Turpeinen M. Transepidermal water loss predicts systemic absorption of topical hydrocortisone in atopic dermatitis [letter]. Br J Dermatol 1996; 135: 497-498.
64. Benfeldt E, Serup J, Menne T. Effect of barrier perturbation on cutaneous salicylic acid penetration in human skin: In vivo pharmacokinetics using microdialysis and non-invasive quantifi cation of barrier function. Br J Dermatol 1999; 140: 739-748.
65. Shani J, Barak S, Levi D, et al. Skin penetration of minerals in psoriatics and guinea-pigs bathing in hypertonic salt solutions. Pharmacol Res Commun 1985; 17: 501-512.
66. Schaefer H, Zesch A, Stuttgen G. Penetration, permeation, and absorption of triamcinolone acetonide in normal and psoriatic skin. Arch Dermatol Res 1977; 258: 241-249.
67. White PJ, Gray AC, Fogarty RD, et al. C-5 propyne-modifi ed oligonucleotides penetrate the epidermis in psoriatic and not normal human skin after topical application. J Invest Dermatol 2002; 118: 1003-1007.
68. Gould AR, Sharp PJ, Smith DR, et al. Increased permeability of psoriatic skin to the protein, plasminogen activator inhibitor 2. Arch Dermatol Res 2003; 295: 249-254.
69. Scheuplein RJ. Properties of the skin as a membrane. Adv Biol Skin 1972; 12: 125-152.
70. Otberg N, Richter H, Schaefer H, et al. Variations of hair follicle size and distribution in different body sites. J Invest Dermatol 2004; 122: 14-19.
71. Lu GW, Ciotti SN, Valiveti S, et al. Targeting the pilosebaceous gland. In: Walters KA, Roberts MS, eds. Dermatologic, Cosmeceutic and Cosmetic Development. Informa Healthcare, New York, 2008; 169-188.
72. Scheuplein RJ. Mechanism of percutaneous adsorption. I. Routes of penetration and the influence of solubility. J Invest Dermatol 1965; 45: 334-346.
73. Scheuplein RJ, Blank IH. Permeability of the skin. Physiol Rev 1971; 51: 702-747.
74. Harada K, Murakami T, Yata N, et al. Role of intercellular lipids in stratum corneum in the percutaneous permeation of drugs. J Invest Dermatol 1992; 99: 278-282.
75. Bodde HE, Van Den Brink I, Koerten H, et al. Visualization of in vitro percutaneous penetration of mercurin chloride: Transport through intercellular space versus cellular uptake through desmosomes . J Control Release 1991; 15: 227-236.
76. Kim YH, Ghanem AH, Higuchi WI. Model studies of epidermal permeability. Semin Dermatol 1992; 11: 145-156.
77. Cooper ER, Kasting GB. Transport across epithelial membranes. J Control Rel 1987; 6: 23-35.
78. Watkinson AC, Brain KR. Mathematical principles in skin permeation. In: Walters KA, ed. Dermatological and Transdermal Formulations. Marcel Dekker, New York, 2002; 61-88.
79. Roberts MS, Cross SE, Pellett MA. Skin transport. In: Walters KA, ed. Dermatological and Transdermal Formulations. Marcel Dekker, New York, 2002; 89-196.
80. Lian G, Chen L, Han L. An evaluation of mathematical models for predicting skin permeability. J Pharm Sci 2008; 97: 584-598.
81. Hadgraft J. Skin deep. Eur J Pharm Biopharm 2004; 58: 291-299.
82. Pugh WJ, Degim IT, Hadgraft J. Epidermal permeability-penetrant structure relationships: 4, QSAR of permeant diffusion across human stratum corneum in terms of molecular weight, H-bonding and electronic charge. Int J Pharm 2000; 197: 203-211.
83. Pugh WJ, Roberts MS, Hadgraft J. Epidermal permeability-Penetrant structure relationships: 3. The effect of hydrogen bonding interactions and molecular size on diffusion across the stratum corneum. Int J Pharm 1996; 138: 149-165.
84. Flynn GL, Yalkowsky SH. Correlation and prediction of mass transport across membranes. I. Infl uence of alkyl chain length on fl ux-determining properties of barrier and diffusant. J Pharm Sci 1972; 61: 838-852.
85. Bronaugh RL, Congdon ER. Percutaneous absorption of hair dyes: Correlation with partition coeffi cients. J Invest Dermatol 1984; 83: 124-127.
86. Barry BW, Harrison SM, Dugard PH. Vapour and liquid diffusion of model penetrants through human skin; correlation with thermodynamic activity. J Pharm Pharmacol 1985; 37: 226-236.
87. Anderson BD, Higuchi WI, Raykar PV. Heterogeneity effects on permeability-partition coeffi cient relationships in human stratum corneum. Pharm Res 1988; 5: 566-573.
88. Idson B. Percutaneous absorption. J Pharm Sci 1975; 64: 901-924.
89. Scheuplein RJ, Blank IH, Brauner GJ, et al. Percutaneous absorption of steroids. J Invest Dermatol 1969; 52: 63-70.
90. Kasting GB, Smith RL, Cooper ER. Effect of lipid solubility and molecular size on percutaneous absorption. Pharmacol Skin 1987; 1: 138-153.
91. Flynn GL. Mechanism of percutaneous absorption from physicochemical evidence. In: Bronaugh RL, Maibach HI, eds. Percutaneous Absorption. Marcel Dekker Inc, New York, 1985; 17-52.
92. Rawlings AV, Matts PJ. Dry skin and moisturizers. In: Walters KA, Roberts MS, eds. Dermatologic, Cosmeceutic and Cosmetic Development. Informa Healthcare, New York, 2008; 339-371.
93. Rawlings AV, Harding CR. Moisturization and skin barrier function. Dermatol Ther 2004; 17 (Suppl 1): 43-48.
94. Verdier-Sevrain S, Bonte F. Skin hydration: A review on its molecular mechanisms. J Cosmet Dermatol 2007; 6: 75-82.
95. Roberts MS, Bouwsta JA, Pirot F, et al. Skin hydration-a key determinant in topical absorption. In: Walters KA, Roberts MS, eds. Dermatologic, Cosmeceutic and Cosmetic Development. Informa Healthcare, New York, 2008; 115-128.
96. Benson HAE. Transdermal drug delivery: Penetration enhancement techniques. Curr Drug Deliv 2005; 2: 23-33.
97. Wickett R, Visscher M. Structure and function of the epidermal barrier. Am J Infect Control 2006; 34: S98-S110.
98. Mohammed Y, Prow T. unpublished data.